Identifying a risk profile for thyroid cancer
The large use of simple and effective diagnostic tools has significantly contributed to the increase in diagnosis of thyroid cancer over the past years. However, there is compelling evidence that most micropapillary carcinomas have an indolent behavior and may never evolve into clinical cancers. Therefore, there is an urgent need for new tools able to predict which thyroid cancers will remain silent, and which thyroid cancers will present an aggressive behavior. There are a number of well-established clinical predictors of malignancy and recent studies have suggested that some of the patients laboratory data and image methods may be useful. Molecular markers have also been increasingly tested and some of them appear to be very promising, such as BRAF, a few GST genes and p53 polymorphisms. In addition, modern tools, such as immunocytochemical markers, and the measure of the fractal nature of chromatin organization may increase the specificity of the pathological diagnosis of malignancy and help ascertain the prognosis. Guidelines designed to select nodules for further evaluation, as well as new methods aimed at distinguishing carcinomas of higher aggressiveness among the usually indolent thyroid tumors are an utmost necessity.
Main Authors: | Ward,Laura Sterian, Morari,Elaine Cristina, Leite,Janaina Luisa, Bufalo,Natassia Elena, Guilhen,Ana Carolina Trindade, Araujo,Priscilla Pereira C. de, Tincani,Alfio J., Assumpção,Ligia V.M., Matos,Patricia Sabino |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Endocrinologia e Metabologia
2007
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302007000500008 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer
by: Cunha,Lucas Leite, et al.
Published: (2011) -
Lack of mutation in exon 10 of p53 gene in thyroid tumors
by: Lia Santarosa,Patricia, et al.
Published: (2004) -
Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas
by: Cunha,Lucas Leite, et al.
Published: (2012) -
Comparative analysis of the new guidelines and consensuses for the management of hypothyroidism, thyroid nodules, and differentiated thyroid cancer
by: Paz-Filho,Gilberto, et al.
Published: (2013) -
Clinical utility of TGFB1 and its receptors (TGFBR1 and TGFBR2) in thyroid nodules: evaluation based on single nucleotide polymorphisms and mRNA analysis
by: Peres,Karina Colombera, et al.
Published: (2021)